Memantine ER capsules recalled for failed dissolution specifications
Major Pharmaceuticals is recalling memantine hydrochloride extended-release 7 mg capsules (lot N02425, expiring 05/31/2027) because the capsules may not dissolve properly in the body. This means the medication may not work as intended. The affected capsules were distributed nationwide.
From the FDA notice · Read the official notice ↗ · All The Harvard Drug recalls
What to do
- Contact your pharmacist or doctor if you have this medication
- Do not take capsules from lot N02425 without talking to your doctor first
- Your doctor may prescribe an alternative or provide a replacement
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61
- Sold in
- Nationwide
- Made for
- Older adults (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 7000 Cardinal Pl, N/A, Dublin, OH, United States
- Classification
- Class II
- Recall number
- D-0485-2026
In the FDA's words
- Description
- Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61 Failed Dissolution Specifications Lot # N02425, Exp Date: 05/31/2027. Distribution: US Nationwide. Affected quantity: N/A
- Hazard
- Failed Dissolution Specifications